Madison Avenue Partners LP 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 11:10 am Purchase | 2023-12-31 | 13G | Ovid Therapeutics Inc. OVID | Madison Avenue Partners LP | 3,648,509 5.200% | 39,455 (+1.09%) | Filing |
| 2023-07-31 5:21 pm Purchase | 2023-07-20 | 13G | Ovid Therapeutics Inc. OVID | Madison Avenue Partners LP | 3,609,054 5.100% | 3,609,054 (New Position) | Filing |